Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ...

FDA approves Novo Nordisk's Alhemo for hemophilia A and B with inhibitors. Once-daily shot reduces bleeding episodes in ...

Iowa has its first confirmed case of H5N1 bird flu in a poultry farm worker, the state's public health department announced.

A regional online seminar organized by UAE Hemophilia Group brought together 19 prominent experts and specialists of Hematology. The online event’s main goal was to create awareness on the challenges ...

Former Manila Mayor Isko Moreno Domagoso has channeled over P100 million from his talent fees to support various programs ...

Novo Nordisk shares on the NYSE rose over 5% in premarket trading Monday, reversing some losses from Friday’s plunge that ...

Analysts have set 12-month price targets for Novo Nordisk, revealing an average target of $145.25, a high estimate of $160.00 ...

In a report released today, Elmar Kraus from DZ BANK AG maintained a Hold rating on Novo Nordisk (0QIU – Research Report). The company’s shares ...

作为全球首款 [ ...

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production ...